Genetics of Cardiovascular and Neuromuscular Disease

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Jan 2026 to Jan 2030v12
  2. Primary and study completion dates: Jan 2025 to Jan 2026v11
  3. Study completion date: Jan 2025v10
  4. Re-verified, no change to tracked fieldsv9
  5. Primary completion date: Jan 2025
    • Publications: 18 to 39
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Site contact updatedv7
  2. Re-verified, no change to tracked fieldsv6
  3. Publications: details revised at 1 of 18 entriesv5
  4. 2 versions Re-verified since Apr 3, 2006, no change to tracked fieldsv3-v4
  5. Publications: 2 to 18v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
We are studying the genetics of human cardiovascular and neuromuscular disease. There are many different genetic regions that have been associated with the development of cardiomyopathy. An equal number of genetic regions have been associated with muscular dystrophy and there is overlap because some of the identical genes, when mutated, produce both cardiomyopathy and muscular dystrophy. We are working to identify genes and gene mutations associated with cardiomyopathy, arrhythmias and muscular dystrophy. We propose to screen these samples for mutations in genes known to be involved in these disorders.
Trial Details
NCT Number NCT00138931
Lead Sponsor University of Chicago
Conditions
(from sponsor)		 Cardiomyopathy, Arrhythmia, Muscular Dystrophy
Related terms Arrhythmias, Cardiac, Cardiomyopathies, Muscular Dystrophies
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov